Skip to search formSkip to main contentSkip to account menu

O44, octane

Known as: O44, solvent 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

Hydrocarbons, FluorinatedOctanes

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
OPGr o44 - Omega 3 reduz a inflamação dos tecidos periapicais de ratos com infecção endodôntica
O objetivo deste estudo foi avaliar os efeitos da suplementacao alimentar com o acido graxo omega-3 na expressao de mediadores… 
2016
2016
O44-1 Pestipop: a french generic job-exposure matrix for use in epidemiological studies on occupational exposure to pesticides
Occupational exposure to pesticides concerns a wide population of workers, not only in agriculture but in numerous other… 
2016
2016
PgO - o44 Ação da dose oncológica de zoledroanato sobre eventos que regulam o processo de reparação dos tecidos moles sobrejacentes ao sítio de extração dental
Este estudo avaliou como o zoledronato afeta eventos que regulam o reparacao dos tecidos moles sobrejacentes ao sitio de extracao… 
2011
2011
O44-4 小児における咳嗽の客観的なモニタリングの試み : 第3報(O44 小児気管支喘息3 モニタリング,口演,第61回日本アレルギー学会秋季学術大会)
2010
2010
O44-2 本邦のアレルギー性鼻炎有病率とその危険因子 : 日本語版ECRHS調査票による疫学調査(O44 鼻アレルギー,口演,第60回日本アレルギー学会秋季学術大会)
2010
2010
O44-3 アレルギー性鼻炎合併喘息全国実態調査 : SACRAサーベイ 第二報(O44 鼻アレルギー,口演,第60回日本アレルギー学会秋季学術大会)
2010
2010
O44 Détection d’adiponectine circulante malgré l’absence de tissu adipeux dans la lipodystrophie congénitale liée aux mutations de la seipine
2007
2007
O44 建築ファサード群の印象評価に影響を及ぼす空間色彩分布特性に関する研究(色彩心理(b),口頭発表,第38回全国大会要旨集)
2000
2000
O44 鼻粘膜血管内皮細胞におけるNF-κB活性及びVCAM-I発現に対するCetirizineの効果
1999
1999
[O44--a solvent for silicone oil adhesions on intraocular lenses].
AIM To examine the efficiency of O44, a partial fluorinated octane, as a solvent for silicone oil adhesions on intraocular lenses… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)